Release Date: 08/08/14 12:43 Summary: Becoming a substantial holder Price Sensitive: No Download Document 129.82KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling